The National Anti-Doping Agency (NADA) has released the details of the Court of Arbitration of Sports (CAS) decision in the Nirupama Devi methylhexaneamine (MHA) case, making it clear that, other than being suspended for two years, the judoka will have to forego all competitive results she had obtained from the date of her testing ‘positive.’

NADA had collected Nirupama’s urine samples during the National judo championship in Kolkata on January 11, 2012 and she had returned a positive result for prohibited stimulant MHA.

However, two Indian panels had let her off with a reprimand on the argument that the beauty products she purportedly used contained geranium which in turn was the source of MHA.

The World Anti-Doping Agency (WADA) had moved CAS against the decision of the Indian panels in November last year. “The CAS panel found that the VLCC products, which the athlete claimed to have used, did not contain MHA and the MHA concentration as detected in the athlete’s urine sample was on much higher side (2000 ng/ml). This also indicated that the source of MHA in athlete’s body was oral and not by any cutaneous absorption (as pleaded by the athlete in her defence). And because the athlete failed to explain the source of the MHA in her body, the ineligibility cannot be reduced under Article 10.4 or 10.5,” said a NADA release.


While handing a sanction of two years of ineligibility starting from May 1 this year, the CAS ordered that “the period of voluntary provisional suspension served by her (89 days) shall be credited against the total period of ineligibility to be served.”

Besides, as per the CAS decision, Nirupama’s competitive results from January 11, 2012 would be annulled “with all the resulting consequences including forfeiture of medals, points and prizes.”

  • NADA had collected samples during the National judo championship in Kolkata on January 11, 2012

  • More In: SPORT | Today's Paper